Ingemar Carlstedt
- Pharmaceutical Science top 2%
- Immunology top 5%
- Galectins and Cancer Biology 12
- Cell Biology top 2%
- Proteoglycans and glycosaminoglycans research 13
- Small Animals top 2%
- Molecular Biology top 5%
- Glycosylation and Glycoproteins Research 49
-
- Carbohydrate Chemistry and Synthesis 25
-
- Helicobacter pylori-related gastroenterology studies 11
-
- Monoclonal and Polyclonal Antibodies Research 8
-
- Microbial Metabolites in Food Biotechnology 7
-
- Polysaccharides and Plant Cell Walls 7
- Co-authors
- Julia R. DaviesJohn K. SheehanHans W. HOVENBERGClaes WickströmDavid J. ThorntonAnnkatrin HerrmannSara K. LindénHenrik Nordman
- Journals
- Biochemical Journal (19 papers)Biochemical Society Transactions (5 papers)Journal of Biological Chemistry (4 papers)
- Partner nations
- SwedenUnited KingdomDenmark
In The Last Decade
Ingemar Carlstedt
66 papers receiving 3.5k citations
Peers
Comparison fields: 5 of 125
- Pharmaceutical Science 226
- Immunology 699
- Cell Biology 518
- Small Animals 199
- Molecular Biology 1.8k
Countries citing papers authored by Ingemar Carlstedt
This map shows the geographic impact of Ingemar Carlstedt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingemar Carlstedt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingemar Carlstedt more than expected).
Fields of papers citing papers by Ingemar Carlstedt
This network shows the impact of papers produced by Ingemar Carlstedt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingemar Carlstedt. The network helps show where Ingemar Carlstedt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ingemar Carlstedt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 130 | |
| 2 | 2007 | 2 | |
| 3 | 2007 | 68 | |
| 4 | 2003 | 68 | |
| 5 | 2003 | 1 | |
| 6 | H-pylori infection decreases expression of normal (MUC5AC) and increases expression of precancerous (MUC2) apomucins in non human primates (vol 49, pg 809, 2001) | 2002 | 1 |
| 7 | 2001 | 54 | |
| 8 | 2001 | 26 | |
| 9 | 1999 | 48 | |
| 10 | 1999 | 9 | |
| 11 | 1998 | 17 | |
| 12 | 1998 | 23 | |
| 13 | 1997 | 48 | |
| 14 | 1996 | 44 | |
| 15 | 1996 | 195 | |
| 16 | 1991 | 17 | |
| 17 | 1989 | 112 | |
| 18 | 1989 | 35 | |
| 19 | 1987 | 15 | |
| 20 | 1984 | 83 |
About Ingemar Carlstedt
Ingemar Carlstedt is a scholar working on Organic Chemistry, Cell Biology, Molecular Biology, Immunology and Nutrition and Dietetics, having authored 66 papers that have together received 3.6k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (49 papers), Carbohydrate Chemistry and Synthesis (25 papers), Proteoglycans and glycosaminoglycans research (13 papers), Galectins and Cancer Biology (12 papers), Helicobacter pylori-related gastroenterology studies (11 papers), Monoclonal and Polyclonal Antibodies Research (8 papers), Microbial Metabolites in Food Biotechnology (7 papers) and Polysaccharides and Plant Cell Walls (7 papers). The work is most often cited by research in Pharmaceutical Science (226 citations), Immunology (699 citations), Cell Biology (518 citations), Small Animals (199 citations) and Molecular Biology (1.8k citations). Ingemar Carlstedt has collaborated with scholars based in Sweden, United Kingdom and Denmark. Frequent co-authors include Julia R. Davies, John K. Sheehan, Hans W. HOVENBERG, Claes Wickström, David J. Thornton, Annkatrin Herrmann, Sara K. Lindén, Henrik Nordman, Gitte V. Eriksen and Thomas Borén. Their work appears in journals such as Biochemical Journal, Biochemical Society Transactions, Journal of Biological Chemistry, Novartis Foundation symposium and The Journal of Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.